Patient-ventilator Interaction During NIV With Helmet: a Comparison Between PSV and the New NIV NPS Software

January 3, 2024 updated by: Davide Colombo, ASL Novara

The goal of this clinical trial is to evaluate if neural pressure support ventilation is able to improve patient-ventilator synchrony, in ICU patients undergoing non-invasive ventilation (NIV). The main question it aims to answer is:

• Is neural pressure support ventilation better than the pressure support ventilation with respect to patient-ventilator synchrony during helmet NIV?

Researchers will compare neural pressure support ventilation versus pressure support ventilation (Gold standard assisted mode in Europe) to see if the new mode improve patient-ventilator synchrony.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Non-Invasive Ventilation (NIV) has found many different uses in clinical settings, shortening intubation times and preventing orotracheal intubation. NIV success is highly affected by patient comfort and patient-ventilator synchrony. The helmet is one of the most comfortable interfaces, even if synchrony is low due to dead space. The use of Neurally Adjusted Ventilatory Assist (NAVA), in which the Electrical Activity of the Diaphragm (EAdi) drives the ventilator, has shown improvement in comfort and synchrony but still some limitation with helmet, due to the long pressurization time. Pressure-Support Ventilation (PSV) is still the most used and diffused assisted mode in Europe due to its simplicity and effectiveness in helmet-NIV. The aim of this study is to test a new ventilation software called Neural Pressure Support Ventilation (nPSV), which merges the rapid pressurization of PSV along with the EAdi trigger, onto a population of 24 critical care patients ventilated with a helmet NIV.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Novara
      • Borgomanero, Novara, Italy, 28021
        • SS. Trinità Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients (>18aa)
  • Non Invasive Ventilation with helmet
  • NG tubing for clinical use in position
  • Invasive arterial monitoring for clinical use in position

Exclusion Criteria:

  • Unable to express consent
  • Expected NIV < 24hrs
  • Gastric-esophageal surgery in the preceding 12 months
  • Upper-GI bleeding in the last 30 days
  • History of esophageal varices
  • Recent trauma or facial surgery
  • Haemodynamic instability even a after liquid infusion (need of at least dopamine >5 γ/kg/min or norepinephrine >0.1 γ/kg min to obtain systolic pressure >90 mmHg)
  • Core temperature >30 C°
  • Coagulation disorders (INR > 1.5 and/or aPTT >44 sec)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: nPSV first
Patients will follow the pattern: nPSV -> PSV -> nPSVo -> PSVo
Ventilation with neurally adjusted modes or pressure support modes
Experimental: PSV first
Patients will follow the pattern: PSV -> nPSV -> PSVo -> nPSVo
Ventilation with neurally adjusted modes or pressure support modes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of synchrony in nPSV v.s PSV
Time Frame: last 2 minutes over 30 minutes registration
Synchrony time [Timesych]: time frame during which both the ventilator and the neural patient inspiratory time are in the inspiratory phase (s)
last 2 minutes over 30 minutes registration

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tidal Volume
Time Frame: last 2 minutes over 30 minutes registration
Tidal Volume (ml)
last 2 minutes over 30 minutes registration
Minute Volume
Time Frame: last 2 minutes over 30 minutes registration
Minute Volume Ventilation (L)
last 2 minutes over 30 minutes registration
Respiratory rate
Time Frame: last 2 minutes over 30 minutes registration
Respiratory Rate (Breath per minute)
last 2 minutes over 30 minutes registration
Inspiratory time
Time Frame: last 2 minutes over 30 minutes registration
Inspiratory Time [Ti] (s)
last 2 minutes over 30 minutes registration
Neural Inspiratory Time
Time Frame: last 2 minutes over 30 minutes registration
Neural Inspiratory Time [Tineu] (s)
last 2 minutes over 30 minutes registration
Inspiratory Neural-Ventilator Coupling
Time Frame: last 2 minutes over 30 minutes registration
Inspiratory Neural-Ventilator Coupling [NCVi] (Percentage): i.e. the time frame during which both the ventilator and the neural signal are into inspiratory phase
last 2 minutes over 30 minutes registration
Peak of Electrical Activity of the diaphragm
Time Frame: last 2 minutes over 30 minutes registration
Peak of Electrical Activity of the diaphragm [EAdi peak] (mcV)
last 2 minutes over 30 minutes registration
Asynchrony index
Time Frame: last 2 minutes over 30 minutes registration
Asynchrony Index (AI): ratio between the number of ineffective efforts, auto-triggers and double triggers and the neural respiratory rate plus auto-triggers (percentage)
last 2 minutes over 30 minutes registration

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood gas analysis pH level
Time Frame: At the end of each 30-minutes trial
pH (-log10H+)
At the end of each 30-minutes trial
Blood gas analysis Oxygen level
Time Frame: At the end of each 30-minutes trial
Concentration of Arterial Oxygen Partial Pressure [PaO2] (mmHg)
At the end of each 30-minutes trial
Blood gas analysis Carbon Dioxide level
Time Frame: At the end of each 30-minutes trial
Concentration of Arterial Carbon Dioxide Partial Pressure [PaCO2] (mmHg)
At the end of each 30-minutes trial
Blood gas analysis Bicarbonate level
Time Frame: At the end of each 30-minutes trial
Concentration of Sodium Bicarbonate [HCO3-] (mEq/L)
At the end of each 30-minutes trial
Blood gas analysis Lactate level
Time Frame: At the end of each 30-minutes trial
Concentration of Lactate [Lac] (mmol/L)
At the end of each 30-minutes trial

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Davide Colombo, MD, PhD, ASL Novara

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

June 1, 2023

Study Completion (Actual)

June 15, 2023

Study Registration Dates

First Submitted

August 9, 2023

First Submitted That Met QC Criteria

August 16, 2023

First Posted (Actual)

August 22, 2023

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 3, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on nPSV and PSV

Subscribe